Table 3.

Interference of HIV-1 Tat peptides on chemokine-driven Vδ2 and Vδ1 T-cell migration: titration of the inhibitory activity of the peptides Tat24-51 and Tat20-39


Tat peptide (ng/mL)

Vδ2 vs IP-10

Vδ1 vs SDF-1
Nil   48 ± 3   38 ± 3  
24-51 (500)   10 ± 2   12 ± 2  
24-51 (50)   29 ± 3   10 ± 1  
24-51 (5)   43 ± 1   39 ± 2  
20-39 (500)   14 ± 3   11 ± 1  
20-39 (50)   36 ± 2   31 ± 3  
20-39 (5)   43 ± 2   41 ± 4  
46-60 (500)   42 ± 1   32 ± 2  
56-70 (500)   39 ± 2   40 ± 3  
65-80RGD (500)   19 ± 3   18 ± 2  
65-80RGE (500)
 
41 ± 4
 
36 ± 3
 

Tat peptide (ng/mL)

Vδ2 vs IP-10

Vδ1 vs SDF-1
Nil   48 ± 3   38 ± 3  
24-51 (500)   10 ± 2   12 ± 2  
24-51 (50)   29 ± 3   10 ± 1  
24-51 (5)   43 ± 1   39 ± 2  
20-39 (500)   14 ± 3   11 ± 1  
20-39 (50)   36 ± 2   31 ± 3  
20-39 (5)   43 ± 2   41 ± 4  
46-60 (500)   42 ± 1   32 ± 2  
56-70 (500)   39 ± 2   40 ± 3  
65-80RGD (500)   19 ± 3   18 ± 2  
65-80RGE (500)
 
41 ± 4
 
36 ± 3
 

γδ T-cell lines, cultured in IL-2-containing medium (25 U/mL) for 3 weeks, were radiolabeled with 51Cr and assayed for migration, in response to IP-10 (50 ng/mL) for Vδ2 or SDF-1 (50 ng/mL) for Vδ1, across HUVEC monolayers using a transwell double-chamber system, in the absence (Nil) or presence of the indicated Tat synthetic peptides (500-5 ng/mL, as indicated). After 60 minutes of transmigration, cells were recovered from the lower chamber, lysed, and counted in a γ-counter. Results are expressed as percentage of migrated cells, mean ± SD from 6 independent experiments for each cell population from 6 donors, calculated as described in “Patients, materials, and methods.”

or Create an Account

Close Modal
Close Modal